IGM Biosciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript

May 19, 2021 / 05:55PM GMT
Brian Abrahams - RBC Capital Markets - Analyst

Hi, good afternoon, everyone. I am Brian Abrahams, Senior Biotech Analyst here at RBC Capital Markets. Our next presenting company is IGM Biosciences, represented by their CEO, Fred Schwarzer. Fred, thanks so much for joining us.

Fred Schwarzer - IGM Biosciences, Inc. - CEO

Thanks very much, Brian.

Questions and Answers:

Brian Abrahams - RBC Capital Markets - Analyst

So, maybe, just to kick things off for those who are newer to the story, can you maybe start off by giving us an overview on your overall platform and why you guys have decided to use IgM antibodies rather than the more traditional IgGs? And we are also curious to learn how you have managed to overcome some of the challenges with IgM technology that have held the field back in the past?

Fred Schwarzer - IGM Biosciences, Inc. - CEO

Sure. Well we've decided to use IgMs (technical difficulty). Sorry for the technical difficulties. We managed to overcome a lot of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot